Drug and Therapeutics Bulletin 1996;34:53-55; doi:10.1136/dtb.1996.34753
Copyright © 1996 by the BMJ Publishing Group Ltd.
Meropenem - an advantageous antibiotic?
Relevant BNF section: 5.1.2
Meropenem (Meronem - Zeneca) follows imipenem1 as the second carbapenem ß-lactam antibiotic to be marketed in the UK. Does meropenem offer therapeutic advantages, particularly when compared with imipenem?
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for email alerts
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Coming soon!
The DTB archive back to 1962, volume 1, issue 1 will soon be available.
